Drug addiction: a curable mental disorder?

被引:42
作者
Liu, Jian-feng [1 ]
Li, Jun-xu [1 ]
机构
[1] SUNY Buffalo, Dept Pharmacol & Toxicol, Univ Buffalo, Buffalo, NY 14203 USA
基金
美国国家卫生研究院;
关键词
drug addiction; pharmacological targets; behavioral treatment; brain stimulation; gene therapy; COGNITIVE-BEHAVIORAL THERAPY; COMPUTER-ASSISTED DELIVERY; N-ACETYLCYSTEINE; BRAIN-STIMULATION; SYNAPTIC PLASTICITY; COCAINE-SEEKING; GENE-EXPRESSION; NEURAL CIRCUITS; IMMUNE-SYSTEM; RECEPTOR;
D O I
10.1038/s41401-018-0180-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug addiction is a chronic, relapsing brain disorder. Multiple neural networks in the brain including the reward system (e.g., the mesocorticolimbic system), the anti-reward/stress system (e.g., the extended amygdala), and the central immune system, are involved in the development of drug addiction and relapse after withdrawal from drugs of abuse. Preclinical and clinical studies have demonstrated that it is promising to control drug addiction by pharmacologically targeting the addiction-related systems in the brain. Here we review the pharmacological targets within the dopamine system, glutamate system, trace amine system, antire-ward system, and central immune system, which are of clinical interests. Furthermore, we discuss other potential therapies, e.g., brain stimulation, behavioral treatments, and therapeutic gene modulation, which could be effective to treat drug addiction. We conclude that, although drug addiction is a complex disorder that involves complicated neural mechanisms and psychological processes, this mental disorder is treatable and may be curable by therapies such as gene modulation in the future.
引用
收藏
页码:1823 / 1829
页数:7
相关论文
共 109 条
  • [71] Depression and substance use comorbidity: What we have learned from animal studies
    Ng, Enoch
    Browne, Caleb J.
    Samsom, James N.
    Wong, Albert H. C.
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2017, 43 (04) : 456 - 474
  • [72] Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders
    Nishi, Akinori
    Shuto, Takahide
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (03) : 259 - 272
  • [73] N-acetylcysteine for treating cocaine addiction - A systematic review
    Nocito Echevarria, Marco Antonio
    Reis, Tassio Andrade
    Capatti, Giulianno Ruffo
    Soares, Victor Siciliano
    da Silveira, Dartiu Xavier
    Fidalgo, Thiago Marques
    [J]. PSYCHIATRY RESEARCH, 2017, 251 : 197 - 203
  • [74] Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83
  • [75] Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
    Pei, Yue
    Asif-Malik, Aman
    Canales, Juan J.
    [J]. FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [76] Psychostimulant-Induced Neuroadaptations in Nucleus Accumbens AMPA Receptor Transmission
    Pierce, R. Christopher
    Wolf, Marina E.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2013, 3 (02):
  • [77] Gene expression induced by drugs of abuse
    Rhodes, JS
    Crabbe, JC
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (01) : 26 - 33
  • [78] GLT-1: The elusive presynaptic glutamate transporter
    Rimmele, Theresa S.
    Rosenberg, Paul A.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2016, 98 : 19 - 28
  • [79] Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
    Roberts-Wolfe, Douglas J.
    Kalivas, Peter W.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2015, 14 (06) : 745 - 756
  • [80] Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits
    Rushworth, Gordon F.
    Megson, Ian L.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2014, 141 (02) : 150 - 159